Jonathan I. Lieber - 14 Mar 2023 Form 4 Insider Report for Rallybio Corp (RLYB)

Role: Chief Financial Officer and Treasurer
Signature: /s/ Michael Greco, Attorney-in-Fact
Issuer symbol: RLYB
Transactions as of: 14 Mar 2023
Net transactions value: +$26,050
Form type: 4
Filing time: 16 Mar 2023, 19:16:36 UTC
Previous filing: 01 Feb 2023
Next filing: 16 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RLYB	Common Stock	Purchase	$26,050	+5,000		$5.21	5,000	14 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.17 to $5.24, inclusive. The reporting person undertakes to provide to Rallybio Corporation, any security holder of Rallybio Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.17 to $5.24, inclusive. The reporting person undertakes to provide to Rallybio Corporation, any security holder of Rallybio Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

Remarks:

Chief Financial Officer and Treasurer